Top Markets
#1 MowCat MowCat +779.42%
#2 Islamic Coin Islamic Coin +152.09%
#3 龙虾 (Lobster) 龙虾 (Lobster) +85.02%
#4 Akedo Akedo +54.20%
#5 Magma Finance Magma Finance +43.48%
#6 SIXSEVEN SIXSEVEN +30.64%
#7 DeXe DeXe +29.84%
#8 MarsCoin MarsCoin +29.20%
#9 Cortex Cortex +26.39%
#10 Pons Pons +16.13%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
株式のランク #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
株価
$25.61
最終同期: 2025-10-10
時価総額
$1.37B
変化（1日）
0.20%
変化（1年）
1.59%
国
US
取引 Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

カテゴリー

Healthcare
Harrow Health, Inc. 8.625% Senior Notes due 2026（HROWL）の配当利回りの履歴
Harrow Health, Inc. 8.625% Senior Notes due 2026（銘柄コード: HROWL）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Harrow Health, Inc. 8.625% Senior Notes due 2026（HROWL）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.58%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
2.09%
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT